2023 annual financial data
Monopar Therapeutics 2023 Operating margin
Monopar Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -8,831,235 USD and net income was -8,402,196 USD.
Operating cash flow was -7,858,293 USD.
Get free Monopar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,831,235 USD
- Net income
- -8,402,196 USD
- Operating cash flow
- -7,858,293 USD